R&D expense · 2011–2025
Qiagen R&D expense
$188M−3.1% · FY2025
Qiagen (QGEN) reported $188M in R&D expense for fiscal 2025, −3.1% year on year.
| Fiscal year | R&D expense | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $188M | −3.1% | Open → |
| FY20242024-12-31 | $193M | −2.5% | Open → |
| FY20232023-12-31 | $199M | +4.6% | Open → |
| FY20222022-12-31 | $190M | −0.1% | Open → |
| FY20212021-12-31 | $190M | +27.4% | Open → |
| FY20202020-12-31 | $149M | −5.3% | Open → |
| FY20192019-12-31 | $157M | −2.7% | Open → |
| FY20182018-12-31 | $162M | +5.0% | Open → |
| FY20172017-12-31 | $154M | +2.8% | Open → |
| FY20162016-12-31 | $150M | +2.1% | Open → |
| FY20152015-12-31 | $147M | −10.3% | Open → |
| FY20142014-12-31 | $164M | +12.0% | Open → |
| FY20132013-12-31 | $146M | +19.3% | Open → |
| FY20122012-12-31 | $122M | −6.2% | Open → |
| FY20112011-12-31 | $131M | — | Open → |
R&D expense — Research and development expense is what the company charged to R&D in the income statement for the year. Most companies report no R&D at all — the line is absent rather than zero — so this ranking covers the roughly 40% of filers that do.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +2.6%
R&D expense at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Qiagen R&D expense |url=https://companiesranked.com/en/company/qiagen/research-and-development-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Qiagen R&D expense. CompaniesRanked. https://companiesranked.com/en/company/qiagen/research-and-development-expenseBibTeX
@misc{companiesranked-en-company-qiagen-research-and-development-expense-2026,
author = {{CompaniesRanked}},
title = {{Qiagen R\&D expense}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/qiagen/research-and-development-expense}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 20-F · 0001015820-26-000018 · March 20, 2026
{{cite web |title=Qiagen R&D expense — 20-F (0001015820-26-000018) |url=https://www.sec.gov/Archives/edgar/data/1015820/000101582026000018/qgen-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-03-20}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.